Dopamine receptor sub-types in gastric and duodenal ulceration

Indian Journal of Pharmacology

Volumn 28, Issue 3, 1996, Pages 129-142

  Desai, J K ^a   Goyal, R K ^a   Parmar, N S ^b  

^a L M COLLEGE OF PHARMACY   (India)

^b K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

cytoprotection; dopamine receptor sub types; duodenal ulcer; gastric ulcer; gastric acid secretion

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; APOMORPHINE; BROMOCRIPTINE; BUTACLAMOL; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; FENOLDOPAM; FLUPHENAZINE; HALOPERIDOL; LERGOTRILE; LEVODOPA; METHYLPHENIDATE; METOCLOPRAMIDE; PIMOZIDE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; ROTIGOTINE; SPIPERONE; SULPIRIDE; UNINDEXED DRUG; YOHIMBINE;

ANIMAL MODEL; BRAIN; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DUODENUM ULCER; GASTROINTESTINAL MOTILITY; HUMAN; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REVIEW; STOMACH ACID SECRETION; STOMACH MUCOSA BLOOD FLOW; STOMACH PROTECTION; STOMACH ULCER; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029820472     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Eaker EY, Bixler BG, Dunn AJ, Moreshead WV, Mathias JR. Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins. J Pharmacol Exp Ther 1987,244:438-42
2. Strang R. The association of gastro-duodenal ulceration and Parkinson's disease. Med J Australia 1965;1:842-3.
3. Hinterhuber H, Hochenegg L. Ulcers, stress and schizophrenia Arch Psychiat Nervenker 1975;220:335-45.
4. Hakanson R Formation of amines in the gastric mucosa of the rat Nature 1965;208 793-6.
5. Christensen NJ, Brandsborg O. Dopamine in human gastric juice determined by a sensitive double-isotope-derivative technique. Scand J Clin Lab Invest 1974;34:315-20
6. Odaibo SK, Cheng WY, Lee KY. Presence and role of local dopamine receptors on antral motility in the isolated perfused rat stomach. Gastroenterology 1983;84:1262-5.
7. Glavin GB, Szabo S. Dopamine in Gastrointestinal disease. Dig Dis Sci 1990;35:1153-61.
8. Szabo S. Dopamine disorder in duodenal ulceration. Lancet 1979;2:880-2.
9. Szabo S, Pihan G. Development and significance of cysteamine and propionitrile models of duodenal ulcer. Chronobiol Int 1987;4:31-42.
10. Caldara R, Ferrari C, Rommusi M, Paracchi A. Effect of bromocriptine administration on gastric acid and gastrin secretion in man. J Endocrinol Invest 1979;2:45-9.
11. Caldara R, Grimoldi D, Ferrari C Bromocriptine, gastric acid output and gastrin secretion Lancet 1977,1:902-5
12. Szabo S. Possible role of brain neurotransmitters and related compounds in the pathogenesis of cysteamine induced duodenal ulcer. Fed Proc 1976;6:1019.
13. Hirst BH, Reed JD, Gomez-Pan A, Labib LA. Bromocriptine potentiation of gastric acid secretion in cats Clin Endocrinol 1976;5:723-9.
14. Parmar NS, Tariq M, Ageel AM Effect of bromocriptine, a dopamine receptor agonist on the experimentally induced gastric ulcers in albino rats. Life Sci 1984;35:2035-9.
15. Szabo S, Brown A, Pihan G, Dali H, Neumeyer JL Duodenal ulcer induced by MPTP (1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine). Proc Soc Exp Biol Med 1985;180.567-71
16. Sikiric P, Geber J, Evanovic E, Suchanek V, Gjaris M, Tucan Foretic S, Civitanovic B, Rotkivic I. Dopamine antagonists induced gastric lesion in rats. Eur J Pharmacol 1986; 131:105-7.
17. Lam SK, Lam KC, Lai CL, Yeung CK, Lam LYC, Wong WS. Treatment of duodenal ulcer with antacid and sulpiride. A double blind controlled study. Gastroenterology 1979;76:315-22.
18. Mihas AA, Mihas TA. A controlled trial of an antacid-sulpiride regimen and cimetidine in the treatment of benign gastric ulcer. Gastroenterology 1981;80.1232-5.
19. Weihrauch TR, Ewe K. A controlled double blind trial of the effect of domperidone on the healing of benign gastric ulceration. "Progress with dompendone: Royal Society of Medicine. London. International Congress and Symposium Series 1981;36:89-95.
20. Hernandez D, Orlando R, Adcock J, Patrick K, Nemeroff C, Prange A Prevention of stress induced gastric ulcers by agonists. Clin Res 1983;31:683A.
21. Hernandez D, Adcock J, Orlando R, Patrick K, Nemeroff C, Prange A Prevention of stress induced gastric ulcers by dopamine agonists in the rat. Life Sci 1984;35:2453-8.
22. Glavin G, Dugani A. Effects of dopamine agonists and antagonists on gastric acid secretion and stress responses in rat. Life Sci 1987,41:1397-9.
23. Chakravorty M Role of dopamine in experimental peptic ulceration: Ph.D thesis of I.M.S., Banaras Hindu University, India 1992
24. 2 agonists and antagonists on experimental gastric lesions and gastric acid secretion. J Pharmacol Expt Therap 1989;252:726-31.
25. Glavin GB Dopamine and Gastroprotection. The brain-gut axis. Dig Dis Sci 1991;36:1670-2.
26. Zeniba T, Fuji K, Fuji Y, Ohya S. Effect of dogmathyl (sulpiride) on gastric movement and gastric mucosal blood flow. Proc. 5th Congress. New Drug Treatment, Osaka: Fujisawa pharmaceutical Co. 1968:48-59.
27. Wada T. Peptic ulcer and gastric mucus secretion Proc 6th Congress. New Drug treatment. Osaka: Fujisawa Pharmaceutical Co 1969.88-95.
28. Caldara R, Romussi M, Ferrari C. Inhibition of gastrin secretion by sulpiride treatment in duodenal ulcer patients Gastroenterology 1978;74:221-3.
29. Desai JK, Parmar NS Effect of sulpiride, a dopamine receptor antagonist, on experimentally induced gastric and duodenal ulcers in rats. Agents and Actions 1994;42-43: 149-53
30. Hara C, Ogawa N. Effects of psychotropic drugs on the development of activity-stress ulcer in rats Japan J Pharmacol 1984;35:474-7
31. Parmar NS, Tariq M, Ageel AM. Al-Khamis K. Effect of domperidone on experimentally induced gastric ulcers in rats. Int J Tiss Reac 1986,8.67-70.
32. Harasawa S, Miwa T. Effects of domperidone on gastric emptying in man. A placebo controlled evaluation. Naika Hokan 1981;28:67-75
33. Lam SK, Lai CL Inhibition of sulpiride on the cephalic phase of gastric acid and gastrin secretion in duodenal ulcer patients Scand J Gastroenterol 1976;11:27-31.
34. Lauterbach H, Mattes P. Effect of dopamine in stress ulcer of rats. Eur Surg Res 1977;9:258-63.
35. Lindvall O, Bjorklund A. Anatomy of the dopaminergic neuron systems of the rat brain. In: Advances in Biochemical Psychopharmacology Roberts P, (ed). New York: Raven Press, 1978:1-23.
36. Szabo S, Horner H, Gallagher GT. Drug induced duodenal ulcer: Structure activity correlations and pathogenesis. Drugs and Peptic Ulcer. Vol.2, C.J. Pfeiffer, Florida: CRC Press Inc. Boca Raton, 1982
37. Jacobson ED, Johanson LR. Survey of opportunities and needs in research on digestive disease. Gastroenterology 1975;69:1071-3.
38. Poulsen SS, Szabo S. Mucosal surface morphology and histologic changes in the duodenum of the rat following administration of cysteamine. Br J Exp Pathol 1977,58:1-5.
39. Giampaolo C, Poulsen SS, Szabo S, Reynolds ES, Feldman D. Stereomicroscopic and ultrastructural characterization of propionitrile induced duodenal ulcer in the rat. Lab Invest 1978;18:1-3.
40. Szabo S, Hollenberg NK. Organ blood flow alterations caused by the duodenal ulcerogens cysteamine and propionitrile. Dig Dis Sci (In Press) 1995.
41. Szabo S, Horner HC Biochemical characterization of duodenal ulcer. Effect of propionitrile or cysteamine on tissue catecholamines and serotonin levels. Fed Proc 1978;37:302-5.
42. Horner HC, Szabo S. Central and peripheral dopamine and noradrenaline in the pathogenesis of cysteamine induced duodenal ulcer disease. Gastroenterology 1980,78:1183-6.
43. Horner HC, Szabo S. Dopamine, dopamine metabolites and dopamine agonists in experimental duodenal ulcer disease. Gastroenterobgy 1979;76:1305-8.
44. Szabo S, Reynolds ES. Structure activity relationships for ulcerogenic and adrenocortical effects of alkyl nitriles, amines and thiols. Environm Health Perspective 1975.11:135-40
45. Szabo S, Horner HC, Bailey KA. Neuropharmacologic and biochemical characterization of chemically induced duodenal ulcer in the rat Paris. Proc 7th Int Cong Pharmacol, 1978:32.
46. Glavin GB, Szabo S. Activity of selective dopamine DA1 and DA2 agonists on experimental gastric lesions and gastric acid secretion. Dig Dis Sci 1990;35:1153-5
47. Oishi T, Szabo S Effect of tyrosine administration on duodenal ulcer induced by cysteamine in the rat J Pharmacol Exp Ther 1987;240:879-82.
48. Nicklas W, Vyas I, Heikkila R. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985;36.2503-8.
49. Cohen G. Oxy-radical toxicity in catecholamine neurons. Neurotoxicology 1984;5:77-82.
50. Glavin G. Central dopamine involvement in gastrointestinal injury. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:217-21.
51. Flemstrom G, Safsten B, Jedstedt G. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology 1993; 104:825-33.
52. Gamer A, Heylings JR, Hampson SE, Stanier AM. Pharmacological profile of duodenal alkaline secretion Aliment Pharmacol Ther 1990;4:465-76.
53. Tatsuta M, Iishi H, Okuda S. Deduction of duodenal ulcer recurrence by healing with cimetidine plus sulpiride. Gut 1986;27:1512-15.
54. Tache Y. Central Nervous System regulation of gastric acid secretion In: Physiology of the Gastrointestinal Tract Jhonson L, (ed). New York: Raven Press, 1987:2:911-30.
55. Chaudhary T, Robert A. Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate Dig Dis Sci 1980;25:830-6.
56. Robert A, Nezamis J, Lancaster C, Davis J, Field Y, Hanchar A Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandin J Physiol 1983;245:G113-21.
57. Robert A, Nezamis JE, Lancaster C, Hanchar AJ Cytoprotection by prostaglandins in rats; prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979;77:433-43.
58. Robert A. Cytoprotection: Definition and concept. Gastroenterol. Clin Biol 1985,12:7-8.
59. 3H-L-dopa by the rat gut in vivo, evidence for glucronide conjugation Biochem. Pharmacol 1975;24:1167-74.
60. 2-adrenoceptors. Dig Dis Sci 1988; 33; 1560-8.
61. DiJoseph JF, Taylor JA, Nabimir G. Alpha-2 receptors in the gastro-intestinal system : A new therapeutic approach. Life Sci 1984;35:1031-42.
62. Ray A, Henke PG, Sullivan RM. Effects of intra-amygdalar dopamine agonists and antagonists on gastric stress lesions in rats. Neuroscience Letters 1988;84:301-6.
63. Kumagai H, Urakawa K, Asaka Y, Ito A, Sano I, Saito Y. Role of dopamine in prevention of stress-induced gastric lesions. Exp Ulcer 1986;14:23 (abstract).
64. Ray A, Khanna A, Sen P. Possible prostaglandin-dopamine interactions during experimental gastric ulcer formation. Ind J Expt Biol 1990;28:562-5.
65. Bhargava KP, Daas M, Gupta GP, Gupta MB. Study of central neurotransmitters in stress induced gastric ulceration in albino rats. Br J Pharmacol 1980,68:765-72.
66. Hernandez DE, Stanley DA, Allen J, Prange AJ. Role of brain neurotransmitters on neurotensin induced cytoprotection. Pharmacol Biochem Behav 1985,22:509-13.
67. Hernandez DE. Neuroendocrine mechanisms of stress ulceration: focus on thyrotropin releasing hormone (TRH). Life Sci 1986;39:279-96.
68. Murakami M, Lam SK, Inada M, Miyake T. Pathophysiology and pathogenesis of acute gastric mucosal lesions after hypothermic restraint stress in rats Gastroenterology 1985;88:660-4.
69. Henke PG. The hypothalamus amygdala axis and experimental gastric ulcers. Neurosci Biobehav Res 1979;3:75-82.
70. Henke PG. The telencephalic limbic system and experimental gastric pathology: a review. Neurosci Biobehav Res 1982.6 381-90.
71. Ray A, Henke PG, Sullivan RM. The central amygdala and immobilization stress induced gastric pathology in rats : Neurotensin and dopamine. Brain Res 1987;409:398-402.
72. Ben-Ari RE, Zigmond, Moore KE. Regional distribution of tyrosine hydroxylase, norepinephrine and dopamine within the amygdaloid complex of the rat. Brain Res 1975;87: 96-101.
73. Fallon JH, Koziell DA, Moore RY. Catecholamine innervation of basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 1978;180 509-32.
74. Leviel V, Charriere B, Fayada C, Guibert B. Nigroamygdaloid dopamine neurons. nigral modulation of their activity. Brain Res 1986;381:205-14
75. Caldara R, Ferrari C, Romussi C, Bierti L Effect of dopamine infusion on gastric and pancreatic secretion and gastrin release in man. Gut 1978;19.724-28.
76. Peringer E, Jemmer P, Marsden CD. Effect of metoclopramide on turnover of brain dopamine, noradrenaline and 5-hydroxytryplamine. J Pharm Pharmacol 1975;27:442-4.
77. Valenzuela JE, Defilippi D, Diaz G, Navia E, Merino J. Effect of dopamine on human gastric and pancreatic secretion. Gastroenterology 1979;76:323-6.
78. Oldendorf WH. Brain uptake of radiolabelled aminoacids, amines and hexoses after arterial injection. Am J Physiol 1971;221:1629-39.
79. Costall B, Naylor R, Tan C. A central site of dopamine agonist action to modify gastric secretion in the rat. Eur J Pharmacol 1985;117:61-9.
80. 2) receptors may mediate the anti-secretory effect of centrally administered neurotensin. Gastroenterology 1987;92:1709.
81. Jain SM. Modification of experimentally induced gastric and duodenal ulcers by calcium channel blockers. Ph.D. Thesis. Gujarat University, India. 1992:23.
82. Uvnas-Wallensten K, Lundberg JM, Efendic S. Dopaminergic control of antral gastrin and somatostatin release. Acta Physiol Scand 1978;103:343-5.
83. Uvnas-Wallensten K, Goiny M. Effect of apomorphine on peripheral venous gastrin and insulin levels in conscious dogs. Acta Physiol Scand 1981;112:155-60.
84. Caldara R, Ferrari C, Romussi M, Barbieri C. Effect of four dopamine receptor antagonists on gastrin secretion in healthy subjects Scand J Gastroenterol 1980;15:481-4.
85. Spitaels JM, Moshal MG, Tawat R, Pillay K. Effect of atropine and metodopramide on serum gastrin response to protein in patients with duodenal ulcers. S Afr Med J 1977,52:69-70.
86. Goiny N, Uvnas-Moberg K. Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine. Arch Pharmacol 1987;336:16-9.
87. Merserau WA, Hinchey EJ. Prevention of phenylbutazone ulcer in the rat by glucose: role of a glucoprivic receptor system. Am J Physiol 1982;242:G429-32.
88. Merserau WA, Hinchey EJ. Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 1982;91:150-5.
89. Garrick T, Buack S, Bass P. Gastric motility is a major factor in cold restraint-induced lesion formation in rats. Am J Physiol 1986;250:G191-9.
90. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesion in rats. Dig Dis Sci 1986;31:1114-22.
91. Pihan G, Kline TJ, Hollenberg NK, Szabo S. Duodenal ulcerogens cysteamine and propionitrile induce gastroduodenal motility alterations in the rat. Gastorenterology 1985;88.989-97.
92. Pihan G, Dupuy D, Brown A, Szabo S. Duodenal hypermotility impairs acid neutralization in experimental duodenal ulceration. Gastroenteralogy 1984;86:1210-12.
93. Nagahata Y, Urakawa T, Koruda H. The effect of dopamine on rat gastric motility Gastroenteralogy Jpn 1992;27:482-7.
94. Lanfranchi GA, Bazz GA. Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon. Eur J Clin Pharmac 1983;24:769-72
95. Brouwers JRBJ, Tytgat GN. Dopamine antagonists, dopamine and duodenal ulcers. Gastroenterology 1980; 79:184-5.
96. Malagelada JR. Dopamine antagonists, dopamine and duodenal ulcers (Lett). Gastroenterology 1980;79:185
97. Guth P, Leung F In: Physiology of the gastrointestinal tract. Johnson L, (ed). New York: Raven Press, 1987:1031-6.
98. Kullman R, Breull W, Reinsberg J, Wassermann K, Konopatzki A. Dopamine produces vasodilation in specific regions and layers of the rabbit gastrointestinal tract. Life Sci 1983;32:145-8.
99. Allen A. Structure and function of gastrointestinal mucus. In: Physiology of the gastrointestinal tract Johnson L, (ed) New York: Raven Press, 1987:617-39.
100. Allen A, Gamer A The mucus and bicarbonate barrier in gastroduodenal defense. IUPHAR Proceedings 1984;3:373-8.
101. De Graff J. Physiology and physiopathology of sulfated glycoprotein and sulfated polysaccharide secretion by the gastric mucosa in the dog. In: Peptic Ulcer, Pfeiffer CJ, (ed) Denmark: Munksgaard Copenhagen, 1971:155-61.
102. Sanyal AK, Pandey BL, Goel RK. The effect of traditional preparation of copper, tambrabhasma on experimental ulcers and gastric secretion J Ethnopharmacol 1982;5: 79-82.
103. Horowitz MI. Gastrointestinal glycoproteins in the glycoconjugates. New York. Academic Press, 1977;1.189-213.
104. Glavin GB, Hall AM. Brain-gut relationship: gastric mucosal defense is also important. Acta Physiol Hung 1992;80: 107-15.